RUSSIAN EXPERIENCE WITH USING MONOCLONAL ANTIBODIES TO B-LYMPHOCYTES (RITUXIMAB) IN SYSTEMIC VASCULITIDES ASSOCIATED WITH NEUTROPHIL CYTOPLASMIC ANTIBODIES (PRELIMINARY RESULTS OF THE RUSSIAN REGISTER NORMA)

In 2013, Russia registered officially the indications for the use of monoclonal antibodies to B-lymphocytes (rituximab, RTM) in systemic vasculitides associated with antineutrophil cytoplasmic antibodies (ANCA-SV). This communication presents the preliminary results of the Russian register of the RT...

ver descrição completa

Detalhes bibliográficos

Principais autores:	T. V. Beketova, E. N. Aleksandrova, T. M. Novoselova, E. G. Sazhina, E. V. Nikolaeva, A. V. Smirnov, V. N. Sorotskaya, E. V. Zemerova, I. F. Nam, N. M. Nikitina, G. S. Arkhangelskaya, Z. R. Bagautdinova, I. N. Dashkov, S. Yu. Chernykh, O. V. Zhirnova, Yu. A. Lushpaeva, L. V. Masneva, I. P. Afanasieva, A. E. Arseniev, I. V. Kondratenko, I. B. Bashkova, S. I. Glukhova, E. L. Nasonov
Formato:	Artigo
Idioma:	Russo
Publicado em:	IMA PRESS LLC 2014-06-01
Colecção:	Научно-практическая ревматология
Assuntos:	systemic vasculitis associated with neutrophil cytoplasmic antibodies wegener's granulomatosis with polyangiitis microscopic polyangiitis eosinophilic granulomatosis with polyangiitis (churg-strauss syndrom) biological anti-b cell therapy rituximab
Acesso em linha:	https://rsp.mediar-press.net/rsp/article/view/1918
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!